SecBot SecBot
Insider Cluster (2 insiders) ·Filed Aug 4, 2026

INCY

INCYTE CORP
NEUTRAL
Impact 3/10
Horizonweeks Processed3mo ago
Insider cluster: 2 insiders, $2.2M total
Actionable Insight • Neutral

Insider sales are immaterial in size relative to market cap and consistent with post-earnings liquidity diversification. The CSO's exercise-and-sell pattern is mechanical (not informational). The President's $1.9M sale is notable in absolute terms but still under 0.01% of market cap. No follow-through action warranted, monitor for larger sales or an unusual increase in selling frequency.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$119.80
T+0 close · Aug 4, 2026 · via day close
Latest settled
−2.50%
T+60 · $116.80
Vs SPY
−2.45%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 5 $119.80entry
  2. T+1 · 3mo ago −1.19%α −1.03% · $118.38
  3. T+5 · 3mo ago +0.81%α +0.46% · $120.77
  4. T+20 · 3mo ago +7.54%α +8.14% · $128.83
  5. T+60 · 19d ago −2.50%α −2.45% · $116.80
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

The CSO and President of R&D at Incyte sold a combined $2.16M in open-market shares in the week following the Q2 2026 earnings release. The CSO's sales were part of a planned exercise-and-sell pattern (option exercises paired with same-day sales), while the President's $1.9M sale was a single large open-market disposition. The total open-market sales represent ~0.009% of the $24B market cap, trivial in proportional terms.

Key Financial Metrics

Direction
selling
Total Value
$2.2M
Insiders
2

Key Facts

  • President Pablo J. Cagnoni sold 15,902 shares at ~$119.70 for ~$1.90M on 2026-07-31
  • CSO Patrick A. Mayes sold 2,167 shares at ~$119.47 for ~$261K on 2026-07-31
  • Mayes also engaged in multiple option exercises and same-day sales on 2026-07-31 and 2026-08-03, totaling ~$4.4M in combined sales across both dates, all paired with derivative exercises, consistent with a pre-planned liquidity/vesting pattern
  • Total open-market sales of ~$2.16M represent ~0.009% of Incyte's $24B market cap
  • The cluster follows Incyte's Q2 2026 beat-and-raise earnings (EPS $2.81 vs $2.15 consensus, revenue $1.67B vs $1.49B), which included a one-time CMS settlement benefit
  • The cluster is strongly C-suite (President of R&D and CSO) but the sales are small in proportional terms and the CSO's trades follow a mechanical exercise-and-sell pattern

Financial Impact

Total open-market sales of ~$2.16M, representing ~0.009% of Incyte's $24B market cap. Negligible proportional impact.

insider ownershipfloat

Risk Factors

  • If additional C-suite sales emerge in the next 30 days, the cluster could signal broader insider distribution
  • The Q2 beat included a $246M one-time CMS benefit, if ex-item revenue trends soften, selling could accelerate

Market Snapshot

Exchange
Nasdaq
Sector
Services-Commercial Physical & Biological Research
Analyst Consensus
52% bullish (33 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-INCY-1785902420714

US Market Status

Market Closed · Opens Wed (11h 54m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 5, 2026